Multiple outlets report on research suggesting a link between tadalafil, an erectile dysfunction medication sold under the brand name Cialis, and an increased risk of developing glaucoma. According to the cited findings, people who take tadalafil could be up to 33% more likely to develop glaucoma than those not taking the drug. The reports frame the issue as a warning for patients and clinicians, emphasizing that the drug is commonly prescribed for erectile dysfunction. The coverage is focused on the reported association and the potential eye safety implications, particularly for patients who use tadalafil over time or as part of regular treatment. The articles do not provide additional detail in the excerpts provided about study design, populations studied, whether the risk estimate accounts for other factors, or how the findings might translate into clinical guidance. Overall, the reporting centers on the scientific claim of an elevated glaucoma risk associated with tadalafil and the need for awareness of possible eye-related side effects.